SCHEMBL16340701

SCHEMBL16340701

O=CCCP(CCC=O)CCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
EGLN1 Q9GZT9 4/20 0.43
ALKBH5 Q6P6C2 1/20 0.43
SUCNR1 Q9BXA5 1/20 0.43
SLC15A2 Q16348 1/20 0.35
MAPK1 P28482 1/20 0.35
SLC13A3 Q8WWT9 1/20 0.35
OR51E2 Q9H255 1/20 0.35
SLC22A6 Q4U2R8 1/20 0.33
MAPT P10636 2/20 0.32
ABCC4 O15439 1/20 0.32
KDM4E B2RXH2 3/20 0.32
KDM5C P41229 3/20 0.32
PHF8 Q9UPP1 3/20 0.32
KDM2A Q9Y2K7 3/20 0.32
KDM6B O15054 2/20 0.32
FOLH1 Q04609 1/20 0.32
GABRR1 P24046 1/20 0.32
TSHR P16473 2/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21377561 1.00 LMNA (0.43) LMNAEGLN1ALKBH5SUCNR1SLC15A2
SCHEMBL40381 0.82 LMNA (0.53) LMNAEGLN1ALKBH5SUCNR1SLC15A2
SCHEMBL28981504 0.82 LMNA (0.53) LMNAEGLN1ALKBH5SUCNR1SLC15A2
Phosphine SCHEMBL1906956 0.79 LMNA (0.50) LMNAEGLN1ALKBH5SUCNR1SLC15A2
Water SCHEMBL4632803 0.79 LMNA (0.50) LMNAEGLN1ALKBH5SUCNR1SLC15A2
Hydrochloric Acid SCHEMBL61373 0.79 LMNA (0.50) LMNAEGLN1ALKBH5SUCNR1SLC15A2
SCHEMBL2121788 0.79 LMNA (0.50) LMNAEGLN1ALKBH5SUCNR1SLC15A2
SCHEMBL20872325 0.79 LMNA (0.50) LMNAEGLN1ALKBH5SUCNR1SLC15A2
Hydrochloric Acid SCHEMBL253519 0.79 LMNA (0.50) LMNAEGLN1ALKBH5SUCNR1SLC15A2
Hydrochloric Acid SCHEMBL38657781 0.79 LMNA (0.50) LMNAEGLN1ALKBH5SUCNR1SLC15A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024146920-A1 DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS ASCENDIS PHARMA OPHTHALMOLOGY DIVISION A/S (DK) 2024-07-11 WO disclosed
EP-3299463-B1 ENZYMATIC ENCODING NUEVOLUTION AS (DK) 2020-10-21 EP disclosed
EP-3299463-A2 ENZYMATIC ENCODING Nuevolution A/S (DK) 2018-03-28 EP disclosed
EP-2348125-B1 Method for the synthesis of a bifunctional complex NUEVOLUTION AS (DK) 2017-06-21 EP disclosed
US-8466107-B2 Fibrin-binding peptides and conjugates thereof BRACCO IMAGING SPA (IT) 2013-06-18 US disclosed
US-20120328512-A1 Fibrin-Binding Peptides and Conjugates Thereof BRACCO IMAGING S.P.A. (IT) 2012-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120328512-A1 Fibrin-Binding Peptides and Conjugates Thereof FGB, F13B, F13A1 LMNA 2412/4885EGLN1 1752/4885ALKBH5 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.